A5018102740- Opioid Use Disorder Treatment
- Substance Abuse Treatment and Outcomes
- HIV, Drug Use, Sexual Risk
- Pharmaceutical Practices and Patient Outcomes
- Pain Management and Opioid Use
- Healthcare Policy and Management
- Prenatal Substance Exposure Effects
- Geriatric Care and Nursing Homes
- Primary Care and Health Outcomes
- Mental Health Treatment and Access
- Heart Failure Treatment and Management
- Health Policy Implementation Science
- Homelessness and Social Issues
- Mental Health and Patient Involvement
- Forensic Toxicology and Drug Analysis
- Emergency and Acute Care Studies
- Adolescent and Pediatric Healthcare
- Hepatitis C virus research
- Erythropoietin and Anemia Treatment
- COVID-19 and Mental Health
- Interprofessional Education and Collaboration
- Telemedicine and Telehealth Implementation
- Frailty in Older Adults
- Quality and Management Systems
- Pharmaceutical industry and healthcare
Oregon Health & Science University
2016-2025
Centre Hospitalier Le Vinatier
2024-2025
Oregon Health and Science University Hospital
2018-2024
Université Claude Bernard Lyon 1
2024
Hospices Civils de Lyon
2024
National Institute on Drug Abuse
2020-2023
National Institutes of Health
2023
Children’s Discovery Museum of San Jose
2021-2022
Portland State University
2021
Qualitative Data Repository
2021
People with substance use disorders (SUD) have high rates of hospitalization and readmission, long lengths stay, skyrocketing healthcare costs. Yet, models for improving care are extremely limited. We performed a needs assessment then convened academic community partners, including hospital, SUD organizations, Medicaid accountable to design model medically complex hospitalized patients SUD. Needs showed that 58% 67% participants who reported active said they were interested in cutting back...
Substance use disorders (SUD) represent a national epidemic with increasing rates of SUD-related hospitalizations. However, most hospitals lack expertise or systems to directly address SUD. Healthcare professionals feel underprepared and commonly hold negative views toward patients Little is known about how hospital interventions may affect providers' attitudes experiences SUD.To explore interprofessional perspectives on integrating SUD treatment care attitudes, beliefs, experiences.In-depth...
For the one in nine hospitalized U.S. adults who have SUD, hospital-based addiction care has critical health benefits. But most hospitals don't offer such care.
Importance The rise of fentanyl and other high-potency synthetic opioids across US Canada has been associated with increasing hospitalizations unprecedented overdose deaths. Hospitalization is a critical touchpoint to engage patients offer life-saving opioid use disorder (OUD) care when admitted for OUD or medical conditions. Observations Clinical best practices include managing acute withdrawal pain, initiating medication OUD, integrating harm reduction principles practices, addressing...
Hospitals are increasingly filled with people admitted for medical and surgical complications of substance use disorder (SUD). Hospitalization can be a reachable moment to engage initiate SUD care. Yet most hospitals do not have systems in place adequately address addiction, providers little no addiction training. There is widespread need protocols tools implement hospital-based We share best practices from our Improving Addiction Care Team (IMPACT). include description interprofessional...
Background: Medications for opioid use disorder (MOUD) and alcohol (MAUD) are effective under-prescribed. Hospital-based addiction consult services can engage out-of-treatment adults in addictions care. Understanding which patients most likely to initiate MOUD MAUD inform interventions deepen understanding of hospitals’ role addressing substance disorders (SUD). Objective: Determine patient- consult-service level characteristics associated with MOUD/MAUD initiation during hospitalization....
Background Injection drug use has far-reaching social, economic, and health consequences. Serious bacterial infections, including skin/soft tissue osteomyelitis, bacteremia, endocarditis, are particularly morbid mortal consequences of injection use. Methods We conducted a population-based retrospective cohort analysis hospitalizations among patients with diagnosis code for substance serious infection during the same hospital admission using Oregon Hospital Discharge Data. examined trends in...
Objectives: Patients with opioid use disorder (OUD) can initiate buprenorphine without requiring a withdrawal period through low-dose (sometimes referred to as “micro-induction”) approach. Although there is growing interest in initiation, current evidence limited case reports and small series. Methods: We performed retrospective cohort study of patients OUD seen by hospital-based addiction medicine consult service who underwent initiation starting during hospital admission. then integrated...
Background: Trust is essential in patient-physician relationships. Hospitalized patients with substance use disorders (SUDs) often experience stigma and trauma the hospital, which can impede trust. Little research has explored role of hospital-based addictions care creating trusting relationships SUDs. This study describes how trust physicians changed among hospitalized people SUDs who were seen by an interprofessional addiction medicine service. Methods: We analyzed data from SUD consult...
This study surveyed US adolescent residential addiction treatment facilities to assess treatments used for adolescents younger than 18 years seeking opioid use disorder.
The expansion of the US opioid epidemic has led to significant increases in infections, such as infective endocarditis (IE), which is tied injection behaviors. We aimed estimate population-level IE mortality rate among people who inject opioids and compare risk death against risks from other causes.